239 Exits 168 F-Prime CapitalGeneral Information Company Description Founded in 1969, F-Prime Capital is a venture capital firm based in Cambridge, Massachusetts. The firm seeks to invest in companies operating in the healthcare, therapeutics, medtech, health information technology, services, fintech...
Amgen has entered a merger agreement to acquire Five Prime Therapeutics for $38 per share in cash or an equity value of approximately $1.9bn. Credit: Kwz~commonswiki / WikiMedia. Amgen(formerly Applied Molecular Genetics) has entered a merger agreement to acquireFive Prime Therapeutics(FPRX) fo...